Abstract:Background: Gambogic acid (GA) is a natural product from the resin of the Garcinia species, which showed significant activity in the induction of apoptosis. It can be one promising lead compound for the design and synthesis of new anticancer drugs. Objective: The objective of the current study is to design novel nitrogen-contained GA derivatives with better anti-cancer activities and study the effect of the introduction of different nitrogen-contained groups on the activity of GA. Methods: The designed 15 derivatives were synthesized via esterification or amidation of 30-carboxylate. The synthetic compounds were characterized via different spectroscopic techniques, including X-ray single crystal diffraction, MS and NMR. The cytotoxic activity of the designed derivatives was evaluated in vitro against A549, HepG-2, and MCF-7 cell lines using methyl thiazolyl tetrazolium (MTT) test. Results: 15 nitrogen-contained GA derivatives were successfully synthesized and established. Based on the IC50 values, compounds 9, 10, 11 and 13 showed stronger inhibitory effects on A549, HepG-2, MCF-7 cell lines than GA, while 9 is the most active compound with IC 50 value of 0.64-1.49 μM. Most derivatives of GA with esterification of C-30 including cyano-benzene ring were generally weaker than those of pyrimidinyl-substituted derivatives. In addition, length of alkyl linkers between C-30 of GA and nitrogen-contained group produced different effects on A549, HepG-2 and MCF-7 cell lines. Conclusion: The structure-activity relationship results show that aromatic substituent and linker length play important roles to improve the anticancer activities, while compound 9 with pyrimidine substituent and C-C-C linkers is the most active derivative against tested cell lines, and is a promising anti-cancer agent for further development.

Synthesis and Biological Evaluation of Glyco-Ga Compounds As Anticancer Agents

Synthesis and Biological Evaluation of Novel Derivatives of Gambogic Acid As Anti-Hepatocellular Carcinoma Agents

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.

Synthesis and Anti-tumor Activity of Novel Glycyrrhetinic Acid Derivatives

Synthesis and Anti-Tumor Evaluation of Novel C-37 Modified Derivatives of Gambogic Acid

Synthesis and Bioevaluation of Gambogic Acid Derivatives as Antitumor Agents

Synthesis and Antitumor Evaluation of Glycyrrhetinic Acid-Dithiocarbamate Hybrids.

Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic Acid Derivatives

Synthesis of Novel Heterocyclic Ring‐Fused 18β‐glycyrrhetinic Acid Derivatives with Antitumor and Antimetastatic Activity

Synthesis and Evaluation of Gambogic Acid Derivatives As Antitumor Agents. Part III.

Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs As Anticancer Agents Targeting EGFR.

Design, Preparation and Studies Regarding Cytotoxic Properties of Glycyrrhetinic Acid Derivatives.

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives

Synthesis and Biological Evaluation of Novel Hydrogen Sulfide Releasing Glycyrrhetic Acid Derivatives.

Discovery of a Highly Potent and Novel Gambogic Acid Derivative As an Anticancer Drug Candidate.

Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid

Design, Synthesis, and Biological Evaluation of the Novel Glycyrrhetinic Acid-Cinnamoyl Hybrids As Anti-Tumor Agents

Synthesis and Biological Evaluations of N′-substituted Methylene-4-(quinoline-4-amino) Benzoylhydrazides As Potential Anti-Hepatoma Agents

Synthesis of glycyrrhetinic acid C3 and C30 derivatives and their antitumor activities in vitro

Synthesis and In vitro anti-cancer Activity evaluation of Glucosamine Derivatives